Literature DB >> 17215637

Usefulness of in-hospital change in B-type natriuretic peptide levels in predicting long-term outcome in elderly patients admitted for decompensated heart failure.

Maxime Cournot1, Philippe Leprince, Sylvain Destrac, Jean Ferrières.   

Abstract

The usefulness of repeated measures of B-type natriuretic peptide (BNP) in elderly subjects with decompensated heart failure to improve risk stratification remains poorly known. This prospective cohort study included 61 consecutive patients older than 70 years (mean age, 82.7 years) hospitalized for decompensated heart failure. Clinical, radiologic, biologic, and echographic data were collected at admission and at discharge. The median BNP level at admission was 1136 pg/mL and the mean change during the hospitalization was -32%. Cardiac death or readmission were best predicted by the change in BNP levels, with the poorest prognosis in patients who did not achieve a decrease of at least 40% (hazard ratio, 4.03; 95% confidence interval, 1.50-10.84 in multivariate analysis). Admission of an elderly patient for decompensated heart failure is a daily situation in clinical practice, in which 2 BNP measurements seem to provide reliable information on long-term prognosis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17215637     DOI: 10.1111/j.1076-7460.2007.05297.x

Source DB:  PubMed          Journal:  Am J Geriatr Cardiol        ISSN: 1076-7460


  5 in total

Review 1.  BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review.

Authors:  Pasqualina L Santaguida; Andrew C Don-Wauchope; Mark Oremus; Robert McKelvie; Usman Ali; Stephen A Hill; Cynthia Balion; Ronald A Booth; Judy A Brown; Amy Bustamam; Nazmul Sohel; Parminder Raina
Journal:  Heart Fail Rev       Date:  2014-08       Impact factor: 4.214

2.  Profiling B-type natriuretic peptide in a stable heart failure population: a valuable adjunct to care.

Authors:  A Jan; N F Murphy; C O'Loughlin; M Ledwidge; K McDonald
Journal:  Ir J Med Sci       Date:  2011-03-03       Impact factor: 1.568

3.  Markers of decongestion, dyspnea relief, and clinical outcomes among patients hospitalized with acute heart failure.

Authors:  Robb D Kociol; Steven E McNulty; Adrian F Hernandez; Kerry L Lee; Margaret M Redfield; Russell P Tracy; Eugene Braunwald; Christopher M O'Connor; G Michael Felker
Journal:  Circ Heart Fail       Date:  2012-12-18       Impact factor: 8.790

4.  Associates of an elevated natriuretic peptide level in stable heart failure patients: implications for targeted management.

Authors:  Aftab Jan; Ian Dawkins; Niamh Murphy; Patrick Collier; John Baugh; Mark Ledwidge; Kenneth McDonald; Chris J Watson
Journal:  ScientificWorldJournal       Date:  2013-12-25

5.  B-type natriuretic peptide predicts 30-day readmission for heart failure but not readmission for other causes.

Authors:  Kelsey M Flint; Larry A Allen; Michael Pham; Paul A Heidenreich
Journal:  J Am Heart Assoc       Date:  2014-06-10       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.